A “New” Kind of Classic Coke: Why Coca-Cola Company (NYSE:KO) Could Send Aurora Cannabis Inc. (TSX:ACB) Blazing Past All-time Highs

Coca-Cola Company (NYSE:KO) could give Aurora Cannabis (TSX:ACB) a boost to $20 if a deal is struck.

| More on:

I, along with many other Fools, have been pounding the table on Aurora Cannabis (TSX:ACB) stock over the past few months at a time when it lagged the broader basket of marijuana stocks. When compared side-by-side to the likes of Canopy Growth (TSX:WEED)(NYSE:CGC) or Tilray, Aurora sure looked like a complete dud of a trade.

But when you consider the fact that today’s hottest pot stocks already have the most predictable positive developments in the rear-view mirror, one has to think that Aurora has substantially more upside than anything else in the industry.

Well-established behemoths across various industries (alcohol, tobacco, pharmaceuticals, and consumer packaged goods) are likely itching to get a puff out of marijuana to spark a new wave of growth that many of us have never seen.

You’ve probably heard enough about Constellation Brands and its upped investment in Canopy. It’s been the talk of the town, and the development has been rocket fuel for Canopy stock.

As I’ve mentioned in many previous pieces, investors should be looking to where the puck’s going to be next, not where it’s at right now. Aurora is where I believe the puck is headed next and its “serious talks” with Coca-Cola Company (NYSE:KO) could mark the start of a rally that could bring the company back in the race with its biggest rival: Canopy Growth.

Not your classic Coke!

Aurora shares soared nearly 17% in a single trading session on news of Coca-Cola’s interest in teaming up to develop a CBD-infused “recovery” beverage.

Before you get too excited about the thought of getting high off Warren Buffett’s favourite beverage, you should know that CBD (cannabidiol) isn’t the cannabis constituent that gets you high. That’s another compound called THC (tetrahydrocannabinol), and unfortunately for recreational stoners, there have yet to be reports of Coca-Cola’s interest in producing a THC-infused version of Coke.

CBD is a non-psychoactive compound derived from cannabis that’s been known to play a role in the easing pain and inflammation. The potential medicinal applications are remarkable, and while the public may be more focused on THC, I believe we’ll begin to see more buzz concerning other cannabinoids, especially among firms that are focused on the medicinal side of weed.

According to a projection from a report issued by the Hemp Business Journal, the CBD consumer market is projected to grow to US$2.1 billion by 2020. That’s a pretty big market, and while everybody has been focusing on THC, Aurora has stealthily grabbed a front-row seat to the explosive and underrated CBD market with its Hempco Food and Fiber acquisition, which is a perfect fit alongside Aurora’s other medical-focused pot assets.

So, what’s next?

Expect Coca-Cola to sign on the dotted line at some point over the next few weeks.

I think Coca-Cola may be looking to dip its toe in the cannabis waters in the same way that Constellation Brands did, but unlike Constellation, I don’t think Coca-Cola is going to open up its chequebook when it comes to investing Aurora.

Instead, I believe that Coca-Cola is going to create a long-term supply relationship with Aurora, and if the future CBD-infused beverage shows promise (they likely will), Coca-Cola is probably going to double down on cannabis infusion by going for a THC-infused beverage next and a line of THC/CBD hybrid drinks of varying ratios.

While Coca-Cola may be up for a small stake in the future, I don’t think such an investment would make sense given Aurora’s in the business of medicinal cannabis, and would likely be a more compelling target for a pharmaceutical giant looking for a hedge.

Foolish takeaway

The Coca-Cola/Aurora talks are promising. I think a joint venture is going to be announced soon with further supply deals at some point down the road.

While many Coca-Cola fans think that a jump into cannabis could hurt the brand’s image, I think the firm’s pot expedition will do profoundly more good than harm for sales, especially when you consider the fact that Coca-Cola was originally a medicinal beverage derived from Coca leaves, a raw material used in the manufacture of cocaine! After all these decades, Coca-Cola is becoming a medicinal beverage again!

I’d buy both Coke and Aurora, right here.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Investing

nugget gold
Metals and Mining Stocks

1 Gold and Silver Mining Stock to Buy in May

Agnico Eagle Mines (TSX:AEM) stock might be a great pick up while gold and silver are in a bit of…

Read more »

ETFs can contain investments such as stocks
Tech Stocks

The Smartest Growth ETF to Buy With $1,000 Right Now

Looking for a growth ETF for your next $1,000 investment? XIT offers long‑term performance and concentrated exposure to Canada’s top…

Read more »

Investor wonders if it's safe to buy stocks now
Dividend Stocks

2 Canadian Dividend Giants to Buy With Rates on Hold

These dividend stocks deserve to be on your radar in an uncertain interest rate environment.

Read more »

woman checks off all the boxes
Dividend Stocks

1 TSX Dividend Stock That Could Be a Lifetime Buy

Do you want a “forever” dividend stock? This power producer blends steady contracts with the coming surge in AI-driven electricity…

Read more »

stocks climbing green bull market
Investing

2 Canadian Stocks Supercharged to Surge in 2026

These Canadian stocks are supercharged for growth and are likely to benefit from solid demand trends and exposure to high-growth…

Read more »

space ship model takes off
Dividend Stocks

2 Growth Stocks Set to Skyrocket in 2026 and Beyond

Two growth stocks, both TSX30 winners last year, are well-positioned to soar higher in 2026 and beyond.

Read more »

person enjoys shower of confetti outside
Bank Stocks

Prediction: This TSX Bank Will Surprise Investors in 2026

Big-bank “boring” can flip into a real surprise when earnings surge and the market is still pricing in caution.

Read more »

GettyImages-1394663007
Dividend Stocks

3 Canadian Dividend Stocks That Could Survive a Recession

Three Canadian dividend stocks with stable cash flows, strong balance sheets, and resilient business models that could hold up in…

Read more »